Pharmacist perspectives and considerations for implementation of therapeutic oncology biosimilars in practice. [electronic resource]
Producer: 20200302Description: 1725-1738 p. digitalISSN:- 1535-2900
- Antineoplastic Agents, Immunological -- therapeutic use
- Bevacizumab -- therapeutic use
- Biosimilar Pharmaceuticals -- therapeutic use
- Drug Approval -- legislation & jurisprudence
- Drug Development -- legislation & jurisprudence
- Humans
- Medical Oncology -- methods
- Molecular Targeted Therapy -- methods
- Neoplasms -- drug therapy
- Pharmacists -- organization & administration
- Pharmacy and Therapeutics Committee -- legislation & jurisprudence
- Rituximab -- therapeutic use
- Trastuzumab -- therapeutic use
- United States
- United States Food and Drug Administration -- legislation & jurisprudence
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.